Fusion protein denileukin diftitox clears psoriasis

October 1, 2001

New York - The fusion protein denileukin diftitox appears effectivein stabilizing and clearing skin lesions in patients with psoriasis vulgaris,according to findings presented by James Krueger, M.D., Ph.D., head of theLaboratory for Investigative Dermatology, The Rockefeller University.